Yamamori Motohiro 山森元博

… Alternative Names

YAMAMORI Motohiro 山森元博

Less

Researcher Number	10444613
Affiliation (Current)	2025: 武庫川女子大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help	2024 – 2025: 武庫川女子大学, 薬学部, 教授 2014 – 2017: 武庫川女子大学, 薬学部, 講師 2010 – 2011: 武庫川女子大学, 薬学部, 講師 2009: 京都大学, 薬学研究科, 助教 2008: 神戸大学, 医学部附属病院, 薬剤師
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy Except Principal Investigator Medical pharmacy / Basic Section 55020:Digestive surgery-related
Keywords	Principal Investigator 遊走 / 腎臓がん / galectin-1 / 臨床薬学 Except Principal Investigator アポトーシス / PPARγ / 膵臓がん / 創薬ターゲット / 腫瘍生物 / ERCC1 … More / troglitazone / プロテオミクス / 腎臓がん / 臨床薬学 / 適正使用 / 代謝拮抗剤 / フッ化ピリミジン系 / がん化学療法 / 大腸癌 Less

胃癌化学療法における新たな治療戦略となる新規因子の同定と臨床的評価Principal Investigator
- Principal Investigator
  
  山森元博
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Mukogawa Women's University
スキルス胃癌微小環境におけるCAF教育-進展機構の解明
- Principal Investigator
  
  山本百合恵
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Osaka Metropolitan University
Role of galectin-1 as a target of suppression and prevention for metastasis of renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  Yamamori Motohiro
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Development for novel therapy for pancreatic cancer by PPARgamma agonists
- Principal Investigator
  
  Okamura Noboru
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Research on the therapy for pancreatic cancer by PPARgamma agonists
- Principal Investigator
  
  OKAMURA Noboru
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Discovery of novel targets for the treatment of renal cell carcinoma based on tumor proteomics
- Principal Investigator
  
  OKAMURA Noboru
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Mukogawa Women's University
Appropriate use of the oral fluoropyrimidine anticancer drugs in patients with colorectal cancer
- Principal Investigator
  
  NISHIGUCHI Kohshi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kyoto Pharmaceutical University

All 2018 2017 2016 2013 2012 2011 2010 2009 2008

All Journal Article Presentation

[Journal Article] Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients2018
- Author(s)
  Kurata Keiji、Yakushijin Kimikazu、Okamura Atsuo、Yamamori Motohiro、Ichikawa Hiroya、Sakai Rina、Mizutani Yu、Kakiuchi Seiji、Miyata Yoshiharu、Kitao Akihito、Kawamoto Shinichiro、Matsuoka Hiroshi、Murayama Tohru、Minami Hironobu
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 81 Issue: 5 Pages: 839-846
- DOI
  10.1007/s00280-018-3550-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K18944
[Journal Article] In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer2017
- Author(s)
  Fujita Megumi、Hasegawa Ai、Yamamori Motohiro、Okamura Noboru
- Journal Title
  
  Journal of Experimental & Clinical Cancer Research
  
  Volume: 36 Issue: 1 Pages: 91-91
- DOI
  10.1186/s13046-017-0557-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K08118, KAKENHI-PROJECT-15K18944
[Journal Article] TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2013
- Author(s)
  H. Omatsu, A. Kuwahara, M. Yamamori, M. Fujita, T. Okuno, I. Miki, T. Tamura, K. Nishiguchi, N. Okamura, T. Nakamura, T. Azuma, T. Hirano, K. Ozawa, M. Hirai.
- Journal Title
  
  Int J Med Sci.
  
  Volume: 10 Issue: 12 Pages: 1755-1760
- DOI
  10.7150/ijms.6749
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.2012
- Author(s)
  Fujita M, Tohji C, Honda Y, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N.
- Journal Title
  
  Int J Med Sci
  
  Volume: 9 Issue: 7 Pages: 555-566
- DOI
  10.7150/ijms.4455
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590225
[Journal Article] Involvement of the mevalonate pathway in anti-proliferative effect of zoledronate on renal cell carcinoma2012
- Author(s)
  Fujita M, Tohi M, Sawada K, Yamamoto Y, Nakamura T, Yagami T, Yamamori M, Okamura N
- Journal Title
  
  ACHN. Oncol Rep
  
  Volume: 27 Pages: 1371-1376
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011
- Author(s)
  Fujita M, Yagami T, Fujio M, Tohji C, Takase K, Yamamoto Y, Sawada K, Yamamori M, Okamura N
- Journal Title
  
  Cancer Lett
  
  Volume: 312 Pages: 219-227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] 15-Deoxy-Δ12, 14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways2011
- Author(s)
  Yamamoto Y, Fuita M, Koma H, Yamamori M, Okamura N, Yagami T
- Journal Title
  
  Biochem Biophys Res Commun
  
  Volume: 410 Pages: 563-567
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cell2011
- Author(s)
  Fujita M, et al
- Journal Title
  
  Oncol.Rep.
  
  Volume: 27 Pages: 1371-1376
- DOI
  10.3892/or.2012.1683
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186, KAKENHI-PROJECT-23790209, KAKENHI-PROJECT-24590225
[Journal Article] Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer2011
- Author(s)
  Seki K, Senzaki K, Tsuduki Y, Ioroi T, Fujii M, Yamauchi, H, Shiraishi Y, Nakata I, Nishiguchi K, Matsubayashi T, Takakubo Y, Okamura N, Yamamori M, Tamura T, Sakaeda T
- Journal Title
  
  Int J Med Sci
  
  Volume: 8 Pages: 210-215
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] VEGF 936C> T is predictive of threshold retinopathy of prematurity in Japanese infants with a 30-week gestational age or less2011
- Author(s)
  Yagi M, Yamamori M, Morioka I, Yokoyama N, Honda S, Negi A, Nakamura T, Okamura N, Okumura K, Sakaeda T, Matsuo M
- Journal Title
  
  Res Rep Neonatol
  
  Volume: 1 Pages: 5-11
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma.2010
- Author(s)
  Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Kaori Kadoyama, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda
- Journal Title
  
  Int.J.Med.Sci. 7
  
  Pages: 48-54
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590144
[Journal Article] TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma2010
- Author(s)
  Kuwahara A, Yamamori M, Fujita M, Okuno T, Tamura T, Kadoyama K, Okamura N, Nakamura T, Sakaeda T
- Journal Title
  
  J Exp Clin Cancer Res
  
  Volume: 29 Pages: 100-100
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590186
[Journal Article] Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2009
- Author(s)
  Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda
- Journal Title
  
  Int.J.Med.Sci. 6
  
  Pages: 305-311
- NAID
  120001887679
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590144
[Journal Article] Three-dimensional, but not two-dimensional, culture results in tumor growth enhancement after exposure to anticancer drugs.2008
- Author(s)
  Chiho Komoto, Tsutomu Nakamura, Nobuko Ohmoto, Hironao Kobayashi, Tatsurou Yagami, Kohshi Nishiguchi, Koichi Iwaki, Akiko Kuwahara, Motohiro Yamamori, Noboru Okamura, Katsuhiko Okumura, Toshiyuki Sakaeda
- Journal Title
  
  Kobe J.Med.Sci. 53
  
  Pages: 335-343
- NAID
  110006648070
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590144
[Presentation] Pharmacokinetics of intravenous mycophenolate mofetil after hematopoietic stem cell transplantation in Japanese population2018
- Author(s)
  Kurata K, Okamura A, Yamamori M, Yakushijin K, Kawaguchi K, Higashime A, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Kawamoto S, Matsuoka H, Minami H
- Organizer
  BMT Tandem Meetings
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K18944
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（２）2016
- Author(s)
  山口京子、川上恵、前沙織、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第136年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-26
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（２）2016
- Author(s)
  山口京子、川上恵、前沙織、長谷川愛、本田陽子、山森元博、岡村昇
- Organizer
  医療薬学フォーラム2016
- Place of Presentation
  びわ湖ホール（滋賀県大津市）
- Year and Date
  2016-06-25
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（１）2016
- Author(s)
  前沙織、川上恵、山口京子、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第136年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-26
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 膵臓がん細胞におけるトログリタゾンの抗腫瘍効果（１）2016
- Author(s)
  前沙織、川上恵、山口京子、長谷川愛、本田陽子、山森元博、岡村昇
- Organizer
  医療薬学フォーラム2016
- Place of Presentation
  びわ湖ホール（滋賀県大津市）
- Year and Date
  2016-06-25
- Data Source
  KAKENHI-PROJECT-15K08118
[Presentation] 腎臓がん細胞の遊走に及ぼすgalectin-1の影響2016
- Author(s)
  山森元博、川上恵、長谷川愛、山口京子、前沙織、大石真子、岡村昇
- Organizer
  第26回日本医療薬学会年会
- Place of Presentation
  京都
- Year and Date
  2016-09-17
- Data Source
  KAKENHI-PROJECT-15K18944
[Presentation] 15デオキシ-デルタ12 14-プロスタグランジンJ2の細胞膜上における標的分子であるHSP70の抗体は神経細胞死を誘導する2012
- Author(s)
  山本泰弘、高馬宏美、藤田恵、山森元博、中村任、岡村昇、矢上達郎
- Organizer
  Neuroscience 2012
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-24590225
[Presentation] 腎細胞癌に対する15-デオキシ-デルタ12, 14-プロスタグランジンJ2と各種抗腫瘍剤との併用による相乗毒性2012
- Author(s)
  山本泰弘、高馬宏美、藤田恵、山森元博、中村任、岡村昇、矢上達郎
- Organizer
  第85回日本薬理学会年会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] ヒト神経膠芽腫細胞におけるテモゾロミドの効果に及ぼす抗てんかん薬の影響2012
- Author(s)
  西口裕子、藤田恵、稲彩乃、本田陽子、山森元博、岡村昇
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍メカニズムの解明2012
- Author(s)
  田路千明、藤田恵、本田陽子、山本泰弘、中村任、矢上達郎、山森元博、岡村昇
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞における15-deoxy-Δ12, 14-prostaglandin J2の抗腫瘍効果2011
- Author(s)
  田路千明、藤田恵、澤田京子、山森元博、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 腎臓がん細胞におけるトログリタゾンの抗腫瘍効果に対するp38 MAPK経路の役割2011
- Author(s)
  藤尾弥希、藤田恵、田路千明、澤田京子、山森元博、山本泰弘、高瀬堅吉、矢上達郎、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] 食道がん化学放射線療法における治療成績とフルオロウラシル血漿中濃度との相関2011
- Author(s)
  〓原晶子、山森元博、岡村昇、片岡和三郎、田村孝雄
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186
[Presentation] ヒト腎臓がん細胞株ACHNに対するZoledronateの抗腫瘍効果2011
- Author(s)
  土肥麻貴子、藤田恵、澤田京子、山森元博、岡村昇
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21590186

1. OKAMURA Noboru (60379401)

# of Collaborated Projects: 3 results

# of Collaborated Products: 20 results
2. FUJITA Megumi (50509966)

# of Collaborated Projects: 2 results

# of Collaborated Products: 12 results
3. NISHIGUCHI Kohshi (80379437)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. SAKAEDA Toshiyuki (00304098)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
5. HIRAI Midori (70228766)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. MINAMI Hironobu (60450574)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. TAMURA Takao (80324929)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
8. 山本百合恵 (30909924)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 八代正和 (60305638)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 杉本敦史 (80897356)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 中村任

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yamamori Motohiro 山森 元博

YAMAMORI Motohiro 山森 元博

Research Projects

Research Products

Co-Researchers

胃癌化学療法における新たな治療戦略となる新規因子の同定と臨床的評価Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

スキルス胃癌微小環境におけるCAF教育-進展機構の解明

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Role of galectin-1 as a target of suppression and prevention for metastasis of renal cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development for novel therapy for pancreatic cancer by PPARgamma agonists

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Research on the therapy for pancreatic cancer by PPARgamma agonists

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Discovery of novel targets for the treatment of renal cell carcinoma based on tumor proteomics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Appropriate use of the oral fluoropyrimidine anticancer drugs in patients with colorectal cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Involvement of the mevalonate pathway in anti-proliferative effect of zoledronate on renal cell carcinoma2012

Author(s)

Journal Title

Data Source

[Journal Article] Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma2011

Author(s)

Journal Title

Data Source

[Journal Article] 15-Deoxy-Δ12, 14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways2011

Author(s)

Journal Title

Data Source

[Journal Article] Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cell2011

Yamamori Motohiro 山森元博

YAMAMORI Motohiro 山森元博